微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | -0.36% | -149.32% | 93.23% | 70/139 | 1.44% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | -5.32% | -276.74% | -817.24% | 95/139 | 4.39% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | -0.58% | -123.67% | -177.33% | 105/139 | 0.51% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 0.75% | -56.14% | 2.74% | 90/139 | 1.91% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 0.73% | 4.29% | -75.75% | 81/139 | 1.04% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 3.01% | 3.08% | 22.86% | 80/139 | 3.05% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 2.45% | -5.77% | 43.27% | 82/139 | 4.75% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 1.71% | 12.5% | 144.29% | 80/139 | 2.98% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 0.7% | 6.06% | -76.03% | 82/139 | 1.65% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 2.92% | -25.32% | 12.31% | 84/139 | 4.92% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 2.6% | -4.06% | 71.05% | 91/139 | 5.8% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 1.52% | -3.18% | 130.3% | 93/139 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 0.66% | -35.29% | -83.12% | 96/139 | 2.28% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 3.91% | -42.58% | 44.28% | 98/139 | 12.93% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 2.71% | -47.58% | 72.61% | 100/139 | 12.7% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 1.57% | -49.84% | 53.92% | 100/139 | 9.24% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 1.02% | -51.89% | -85.02% | 89/139 | 6.21% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 6.81% | -34.01% | 31.72% | 96/139 | 17.28% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 5.17% | -24.75% | 65.18% | 91/139 | 15.82% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 3.13% | -32.4% | 47.64% | 99/139 | 11.46% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 2.12% | -11.67% | -79.46% | 71/139 | 6.18% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 10.32% | 39.65% | 50.22% | 87/139 | 25.47% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 6.87% | 48.38% | 48.38% | 62/139 | 19.63% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 4.63% | 133.84% | 92.92% | 73/139 | 15.03% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 2.4% | 727.59% | -67.52% | 35/139 | 3.37% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 7.39% | 2.5% | 59.61% | 89/139 | 14.24% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 4.63% | -1.7% | 133.84% | 51/139 | 10.37% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 1.98% | 1.02% | 582.76% | 61/139 | 6.65% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 0.29% | 52.63% | -95.98% | 54/139 | 2.68% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 7.21% | 52.75% | 53.08% | 79/139 | 12.87% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 4.71% | 34.57% | 140.31% | 37/139 | 7.11% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 1.96% | 27.27% | 931.58% | 50/139 | 3.2% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 0.19% | 46.15% | -95.97% | 50/139 | 2.61% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 4.72% | 23.88% | 34.86% | 83/139 | 13.76% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 3.5% | 20.69% | 127.27% | 43/139 | 9.4% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 1.54% | -28.7% | 1084.62% | 51/139 | 5.88% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 0.13% | 118.57% | -96.59% | 43/139 | 2.65% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 3.81% | -29.96% | 31.38% | 69/139 | 16.11% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 2.9% | -22.46% | 34.26% | 35/139 | 8.66% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 2.16% | -26.78% | 408.57% | 42/139 | 6.24% | *ST明德 | 23.29% | 行业排名> |
| 2016-03-31 | -0.7% | 76.74% | -112.87% | 34/139 | 2.17% | 健帆生物 | 7.75% | 行业排名> |